000 | 01759nam a22002417a 4500 | ||
---|---|---|---|
999 |
_c10978 _d10978 |
||
003 | MED20160012 | ||
005 | 20240720153041.0 | ||
008 | 180906b xxu||||| |||| 00| 0 eng d | ||
040 | _cFEU-NRMF MEDICAL LIBRARY | ||
041 | _aEnglish | ||
050 | _aMED20160012 | ||
100 |
_aCuadra, Alyssa Joyce L., MD. _eauthor |
||
245 |
_aWhen you can't handle your own storm : _ba case report of a 58 year-old male diagnosed with waldenstrom macroglobulinemia / _cAlyssa Joyce L. Cuadra. |
||
260 |
_aFairview, Quezon City _bDepartment of Medicine, FEU-NRMF, _c2016 |
||
300 |
_a9 pages: _c(in folder) |
||
336 |
_2text _ardacontent |
||
337 |
_2unmediated _ardamedia |
||
338 |
_2volume _ardacarrier |
||
504 | _aIncludes bibliographical references. | ||
520 | _aABSTRACT: This is a case of Waldenstrom Macroglobulinemia in a 58-year-old male who presented with gum bleeding lasting for 10 days after tooth extraction, anemia, dizziness and blurring of vision. Bone Marrow Biopsy showed infiltration by the lymphoplasmacytic cell population and strongly expresses CD 19, CD 20 and CD 138. Serum electrophoresis showed monocloclonal peak concentration noted at the gamma region consistent with monoclonal gammapathy. Systemic chemotherapy is the mainstay of treatment for symptomatic WM. The goal of treatment is symptom relief and reducing the risk of organ damage. A single alkylating agent chlorambucil was used in our patient. According to the National Cancer Institute's database (based on people diagnosed between 2001 and 2010), the overall relative 5-year survival of people with WM is about 78%. Advances in the treatment of WM have led to an improved life expectancy fo people living with the disease. | ||
521 | _aRESDM | ||
942 |
_2lcc _cRE |